I wasn't sure about the applicability of that (multiple studies) formula to this question (I'm still mulling over it as well). If we were talking about multiple teams addressing the same question (e.g. oscillococcinum in cough), I would say yes. It may also apply to addressing the question of homeopathy, but I think one would have to present an argument to justify it. And it leads to a lower PPV. Despite Rodney's protestations, I was trying to boost the numbers by any reasonable means, so I didn't use the formula to combine the probabilities.
I think that the reason it decreases is analogous to making multiple comparisons - any "significant" differences found among multiple comparisons are more likely to be spurious than a significant difference on a single comparison.
I also realize that I deleted the values I had specified for beta and u in the first round (probably when I was revising it for clarity), so I think you used some values that were different than mine. It doesn't affect the magnitude of the outcome, though.
The author gave examples for R in Table 4 (e.g. epdemiology, conventional medicine trials, exploratory research (e.g. microarrays were mentioned in the text)). An R of 0.001 was suggested for exploratory research, and (if you take microarrays as an example) that is exploration that occurs within a somewhat established theoretical framework that provides some indication of constraint to your choices. At best, homeopathy could be considered equivalent to that last choice, but is more likely to be worse (there are no known methods by which homeopathy could work, so it is hard to come up with ways to constrain your choices).
I don't know if you read any more posts in this thread, but I went on to give a numerical example in
#488 of one way to go about estimating true relationships and potential relationships. I can elaborate on this some more, if necessary. And I'd be interested in suggestions for other ways to estimate this parameter.
Linda